Capella BioScience

Capella BioScience is engaged in the discovery and development of monoclonal antibodies (mAbs). It focuses on independently discovering, developing, and commercializing mAb-based drugs for the treatment of cancer, autoimmune diseases, and other conditions, utilizing patented technologies in collaboration with biotechnology and academic partners.